Apixaban used for the management of heparin-induced thrombocytopenia in a 72-year-old woman with lung cancer.

ABSTRACT: Heparin-induced thrombocytopenia (HIT) is a serious adverse reaction to heparin treatment with a high risk of thrombosis. Heparin must be discontinued immediately and replaced with alternative anticoagulants that do not interact with HIT antibodies. In this case, a lung cancer patient, diagnosed with HIT was successfully treated with apixaban.

SUBMITTER: Larsen PB 

PROVIDER: S-EPMC4693689 | biostudies-other | 2015 Dec

REPOSITORIES: biostudies-other